JHATX | NARCX | JHATX / NARCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 19 years | 30 years | - |
Gain YTD | 1.891 | 2.690 | 70% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 459M | 291M | 158% |
Annual Yield % from dividends | 2.75 | 1.16 | 237% |
Returns for 1 year | 4.31 | 9.87 | 44% |
Returns for 3 years | -3.09 | 4.37 | -71% |
Returns for 5 years | 5.15 | 14.82 | 35% |
Returns for 10 years | 34.81 | 39.96 | 87% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EAFGX | 28.16 | 0.49 | +1.77% |
Eaton Vance Focused Growth Opps A | |||
EEMHX | 8.02 | 0.02 | +0.25% |
MFS Emerging Markets Equity Research R6 | |||
JFNCX | 58.22 | 0.01 | +0.02% |
Janus Henderson Global Life Sciences C | |||
VWYGX | 44.71 | N/A | N/A |
Voya Small Cap Growth C | |||
WOOPX | 19.12 | -0.10 | -0.52% |
JPMorgan SMID Cap Equity I |